Cytometry News and Research

RSS
Advanced technology provides a fine-grained picture of lung pathology in COVID-19

Advanced technology provides a fine-grained picture of lung pathology in COVID-19

Potent nanobody binds SARS-CoV-2 spike in an extraordinary manner

Potent nanobody binds SARS-CoV-2 spike in an extraordinary manner

Study shows how ACE2 mutations influence SARS-CoV-2 spike binding in humans and animals

Study shows how ACE2 mutations influence SARS-CoV-2 spike binding in humans and animals

INTEGRA’s electronic pipettes eliminate user fatigue and improve pipetting productivity

INTEGRA’s electronic pipettes eliminate user fatigue and improve pipetting productivity

Amino acids signaling controls whole-body glucose homeostasis, study shows

Amino acids signaling controls whole-body glucose homeostasis, study shows

Research looks at inflammatory nature of lipid nanoparticle component in mRNA vaccines

Research looks at inflammatory nature of lipid nanoparticle component in mRNA vaccines

Dual-action monoclonal antibodies from an original SARS survivor show promise against COVID-19

Dual-action monoclonal antibodies from an original SARS survivor show promise against COVID-19

Study identifies three novel binding receptors for SARS-CoV-2

Study identifies three novel binding receptors for SARS-CoV-2

SARS-CoV-2 can infect blood monocytes and trigger inflammation, finds study

SARS-CoV-2 can infect blood monocytes and trigger inflammation, finds study

Research demonstrates multivalent nanobodies overcome SARS-CoV-2 variant mutations

Research demonstrates multivalent nanobodies overcome SARS-CoV-2 variant mutations

Researchers identify new biomarkers associated with severity of COVID-19

Researchers identify new biomarkers associated with severity of COVID-19

Beckman Coulter Life Sciences launches next-generation CytoFLEX SRT benchtop cell sorter

Beckman Coulter Life Sciences launches next-generation CytoFLEX SRT benchtop cell sorter

Study shows lower antibody cross-reactivity after infection with the B.1.1.7 SARS-CoV-2 variant

Study shows lower antibody cross-reactivity after infection with the B.1.1.7 SARS-CoV-2 variant

Beckman Coulter Life Sciences Debuts Biomek NGeniuS Workstation at AGBT

Beckman Coulter Life Sciences Debuts Biomek NGeniuS Workstation at AGBT

Early antibody response predicts COVID-19 outcome

Early antibody response predicts COVID-19 outcome

Pre-existing cross-reactive HCoV antibodies could protect against SARS-CoV-2

Pre-existing cross-reactive HCoV antibodies could protect against SARS-CoV-2

Study reveals new routes to potential treatments for chronic inflammatory conditions

Study reveals new routes to potential treatments for chronic inflammatory conditions

Transforming immune killer T-cells into 'super soldiers' to fight against cancer

Transforming immune killer T-cells into 'super soldiers' to fight against cancer

What are the changes in the physical phenotype of blood cells in COVID-19?

What are the changes in the physical phenotype of blood cells in COVID-19?

British and South African SARS-CoV-2 variants show some resistance to neutralizing antibodies

British and South African SARS-CoV-2 variants show some resistance to neutralizing antibodies